You are here
Some bladder cancer patients benefit from Roche therapy
A NEWLY approved immunotherapy from Roche Holding proved effective as an initial treatment for some patients with advanced bladder cancer, according to data presented on Sunday.
Results of the mid-stage trial could help make the case that the drug, Tecentriq, should become
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org